
|Videos|December 31, 2015
Dr. Debu Tripathy on Further Investigation Into Immunotherapies in Breast Cancer
Author(s)Debu Tripathy, MD
Debu Tripathy, MD, discusses the further investigation into immunotherapy's role in treating breast cancer.
Advertisement
Debu Tripathy, MD, chair, Breast Medical Oncology, University of Texas MD Anderson Cancer Center, discusses the further investigation into immunotherapy's role in treating breast cancer. Tripathy says while immunotherapy is effective in cancer types that already generate an immune response, breast cancer types such as triple negative responds better to standard therapy despite being immunogenic.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Iberdomide, the First CELMoD for Relapsed/Refractory Multiple Myeloma
2
How the Immune System Drives Nerve Growth in TNBC
3
AMH Testing Predicts Chemotherapy Benefit in RxPONDER Breast Cancer
4
FAQ: When and How to Discontinue Lenalidomide Maintenance in Multiple Myeloma
5



































